MEDICAMEQ
NSEMedicamen Biotech Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹245.35
0.05 (0.02%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹333 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
34.0
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹212.4+15.5%
52W High₹447.65-45.2%
Current Price
₹245.35
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹196.28
Upper Circuit₹294.42
Reference Price
₹245.35
Investment Checklist
Double Top on 1D (BREAKOUT CONFIRMED) — target ₹227.5
Bull Flag on 1D — target ₹272.25
Trend: Price below most MAs — downtrend | Bearish MA stack (20<50<200)
Composite score -36.72 (SELL) with 49.0% confidence
SuperTrend(10,3): Price below SuperTrend (Industry Standard (Swing/Medium-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
49%
Trend
BEARISH
BEARISH
Price below most MAs — downtrend | Bearish MA stack (20<50<200)
EMA20
246.52
EMA50
251.89
EMA200
302.64
Price Action
MIXED
NEUTRAL
Higher Highs2
Higher Lows5
Lower Highs7
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹273.12
₹292.95
₹300.25
₹333.80
₹342.18
Support (Below)
₹245.00
₹222.20
₹217.30
₹212.40
Volume Analysis
TrendINCREASING
Change+75.00%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹242.90
3% Risk₹237.99
5% Risk₹233.08
7% Risk (Custom)
₹228.18Technical Levels
1x ATR (Volatility)₹231.03
2x ATR (Swing)₹216.71
3x ATR (Trend)₹202.39
Immediate Support₹245.00
Financials
Financial Analysis
| Metric | Dec '24 | Mar '25 | Jun '25 | Sep '25 |
|---|---|---|---|---|
| Revenue | ₹45.1 Cr | ₹29.6 Cr | ₹43 Cr | ₹47.2 Cr |
| Net Profit | ₹2.9 Cr | ₹2.4 Cr | ₹2.2 Cr | ₹2.7 Cr |
| EPS | ₹2.30 | — | ₹1.18 | ₹1.56 |
| Operating Profit | ₹6.8 Cr | ₹3.6 Cr | ₹5.1 Cr | ₹5.5 Cr |
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Medicamen Biotech Limited | ₹245.35 | -0.02% | 34.0 | ₹333 Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 19 Sept 2025 | Dividend - Re 1 Per Share | DIVIDEND |
| 19 Sept 2024 | Annual General Meeting/Dividend - Re 1 Per Share | AGM |
| 20 Sept 2023 | Annual General Meeting/Dividend - Re 1 Per Share | AGM |
| 19 Sept 2022 | Annual General Meeting/Dividend - Re 1 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for MEDICAMEQ
View AllNEWS
positive
Business Standard - Markets 44d ago
Medicamen Biotech consolidated net profit rises 59.50% in the March 2026 quarter
Sales rise 104.83% to Rs 60.65 crore
MEDICAMEQHealthcare